{"id":9577,"date":"2026-07-19T23:48:03","date_gmt":"2026-07-19T23:48:03","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/who-drug-information-volume-40-no-2\/"},"modified":"2026-07-19T23:48:03","modified_gmt":"2026-07-19T23:48:03","slug":"who-drug-information-volume-40-no-2","status":"publish","type":"ground_post","link":"https:\/\/godshand.link\/en_gb\/ground_post\/who-drug-information-volume-40-no-2\/","title":{"rendered":"WHO Drug Information – Volume 40, No. 2"},"content":{"rendered":"


\n<\/p>\n

\n
\n
\n
\n \"WHO
\n <\/figure>\n
Download (13.4 MB)<\/span><\/a><\/div><\/div>\n
\n
\n
\n
\n

Overview <\/h3>\n

The second issue of volume 40 for 2026 includes:<\/span><\/p>\n

– Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Palliative First-Line Setting: Pilot Study<\/span><\/p>\n

Consultation Documents<\/strong><\/div>\n
– Bioequivalence For Immediate Release Oral Dosage Forms<\/div>\n
– Model quality assurance system for procurement agencies<\/div>\n
– Points to consider on integration of environmental sustainability strategies and metrics into pharmaceutical manufacturing<\/div>\n
<\/div>\n
Anatomical Therapeutic Chemical\/Defined Daily Dose (ATC\/DDD) Classification\u00a0<\/strong><\/div>\n
– ATC\/DDD Classification (Temporary)<\/div>\n
– ATC\/DDD Classification (Final)<\/div>\n
<\/div>\n
Volume 40, issue 2, concludes with the International Nonproprietary Names (INN) List – Proposed INN List No. 135<\/strong><\/div>\n

\u00a0<\/p>\n<\/p><\/div><\/div>\n

\n
\n
\n
WHO Team<\/div>\n
\n
\nHealth Systems, Access and Data (HSD), <\/span>
\n
\nMedicines and Health Products, Policies and Standards (HPS), <\/span>
\n
\nRegulation and Prequalification (RPQ) <\/span>\n <\/div><\/div>\n
\n
Editors<\/div>\n
World Health Organization<\/div><\/div>\n
\n
Number of pages<\/div>\n
494<\/div><\/div>\n
\n
Reference numbers<\/div>\n
\n
ISBN: <\/strong>9789240123991<\/span><\/div><\/div><\/div>\n
\n
Copyright<\/div>\n


\n
\n
\n
\n
\n <\/a>\n <\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n


\n
Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"

Download (13.4 MB) Overview The second issue of volume 40 for 2026 includes: – Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Palliative First-Line Setting: Pilot Study Consultation Documents – Bioequivalence For Immediate Release Oral Dosage Forms – Model quality assurance system…<\/p>","protected":false},"author":99035,"featured_media":9578,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[1572,1270,1573],"ground_category":[315,316],"class_list":["post-9577","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-drug","tag-information","tag-volume","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/52b86874-8529-488d-903c-8314487c4352\/content","_links":{"self":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/9577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=9577"}],"version-history":[{"count":0,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/9577\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/9578"}],"wp:attachment":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=9577"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=9577"},{"taxonomy":"ground_category","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=9577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}